Deutsche Bank
UTMD icon

Deutsche Bank’s Utah Medical Products UTMD Stock Holding History

Deutsche Bank’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.2K Buy
1,278
+957
+298% +$60.3K ﹤0.01% 3350
2025
Q4 		$18K Sell
321
-2,662
-89% -$154K ﹤0.01% 3530
2025
Q3 		$188K Hold
2,983
– – ﹤0.01% 3088
2025
Q2 		$170K Hold
2,983
– – ﹤0.01% 3045
2025
Q1 		$167K Buy
2,983
+2,276
+322% +$136K ﹤0.01% 3033
2024
Q4 		$43.5K Buy
+707
New +$45.7K ﹤0.01% 3440
2024
Q2 		– Sell
-2,362
Closed -$168K – 3701
2024
Q1 		$168K Hold
2,362
– – ﹤0.01% 2926
2023
Q4 		$199K Sell
2,362
-155
-6% -$12.9K ﹤0.01% 2884
2023
Q3 		$216K Buy
2,517
+192
+8% +$17.7K ﹤0.01% 2732
2023
Q2 		$217K Sell
2,325
-822
-26% -$77.5K ﹤0.01% 2837
2023
Q1 		$298K Buy
3,147
+636
+25% +$58.5K ﹤0.01% 2799
2022
Q4 		$252K Buy
2,511
+22
+0.9% +$2.01K ﹤0.01% 2841
2022
Q3 		$213K Sell
2,489
-227
-8% -$20K ﹤0.01% 2908
2022
Q2 		$233K Sell
2,716
-148
-5% -$12.6K ﹤0.01% 3079
2022
Q1 		$257K Sell
2,864
-220
-7% -$20.2K ﹤0.01% 3118
2021
Q4 		$308K Sell
3,084
-11
-0.4% -$1.12K ﹤0.01% 3131
2021
Q3 		$287K Sell
3,095
-146
-5% -$12.9K ﹤0.01% 3364
2021
Q2 		$276K Sell
3,241
-66
-2% -$5.71K ﹤0.01% 3595
2021
Q1 		$286K Sell
3,307
-213
-6% -$18.7K ﹤0.01% 3438
2020
Q4 		$297K Buy
3,520
+650
+23% +$55.4K ﹤0.01% 3235
2020
Q3 		$229K Buy
2,870
+168
+6% +$13.9K ﹤0.01% 3148
2020
Q2 		$240K Buy
2,702
+480
+22% +$43.1K ﹤0.01% 3046
2020
Q1 		$209K Sell
2,222
-379
-15% -$35.2K ﹤0.01% 2931
2019
Q4 		$280K Buy
2,601
+349
+15% +$35.4K ﹤0.01% 3034
2019
Q3 		$213K Sell
2,252
-1,613
-42% -$150K ﹤0.01% 3152
2019
Q2 		$368K Sell
3,865
-1,729
-31% -$146K ﹤0.01% 3477
2019
Q1 		$491K Buy
5,594
+903
+19% +$79.4K ﹤0.01% 3463
2018
Q4 		$388K Sell
4,691
-4,896
-51% -$431K ﹤0.01% 3491
2018
Q3 		$903K Sell
9,587
-4,657
-33% -$445K ﹤0.01% 3403
2018
Q2 		$1.57M Buy
14,244
+132
+0.9% +$13.8K ﹤0.01% 3120
2018
Q1 		$1.39M Sell
14,112
-10,547
-43% -$941K ﹤0.01% 3113
2017
Q4 		$2M Buy
24,659
+7,002
+40% +$547K ﹤0.01% 2722
2017
Q3 		$1.3M Buy
17,657
+2,555
+17% +$184K ﹤0.01% 2832
2017
Q2 		$1.09M Buy
15,102
+8,070
+115% +$531K ﹤0.01% 2972
2017
Q1 		$437K Sell
7,032
-1,337
-16% -$84.2K ﹤0.01% 3159
2016
Q4 		$607K Buy
8,369
+547
+7% +$35.6K ﹤0.01% 3046
2016
Q3 		$466K Sell
7,822
-166
-2% -$10.6K ﹤0.01% 3233
2016
Q2 		$502K Buy
7,988
+1,080
+16% +$69.7K ﹤0.01% 3273
2016
Q1 		$431K Buy
6,908
+2,076
+43% +$122K ﹤0.01% 3301
2015
Q4 		$281K Buy
4,832
+3,701
+327% +$210K ﹤0.01% 3547
2015
Q3 		$60K Buy
1,131
+200
+21% +$10.9K ﹤0.01% 4352
2015
Q2 		$55K Buy
931
+930
+93,000% +$52.3K ﹤0.01% 4543
2015
Q1 		$0 Sell
1
-613
-100% -$36K ﹤0.01% 5941
2014
Q4 		$35K Buy
614
+583
+1,881% +$32.3K ﹤0.01% 5309
2014
Q3 		$1K Buy
31
+13
+72% +$660 ﹤0.01% 5784
2014
Q2 		$0 Sell
18
-1,874
-99% -$96.2K ﹤0.01% 6068
2014
Q1 		$108K Buy
1,892
+654
+53% +$35.7K ﹤0.01% 4200
2013
Q4 		$70K Sell
1,238
-4,194
-77% -$230K ﹤0.01% 4208
2013
Q3 		$322K Buy
5,432
+2,182
+67% +$119K ﹤0.01% 3811
2013
Q2 		$175K Buy
+3,250
New +$153K ﹤0.01% 3912

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank's UTMD Position: Q1 2026 in Review

Deutsche Bank increased its Utah Medical Products (UTMD) stake by 298% in Q1 2026, buying an estimated $60.3K and bringing the position to 1,278 shares worth $79.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3350.

Deutsche Bank first reported a position in UTMD in Q2 2013 and has held it in 50 quarters since. The position peaked at $2M in Q4 2017. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Deutsche Bank held 1,278 shares of Utah Medical Products worth $79.2K as of Q1 2026.
  • Deutsche Bank bought 957 Utah Medical Products shares in Q1 2026, an estimated $60.3K.
  • Utah Medical Products made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3350 holding.
  • Deutsche Bank first reported a position in Utah Medical Products in Q2 2013 and has held it in 50 quarters since.
  • Deutsche Bank's Utah Medical Products position peaked at $2M in Q4 2017.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.